References
Reddingius RE, Schröder CH, Monnens LA (1992) Intraperitoneal administration of recombinant human erythropoietin in children on continuous ambulatory peritoneal dialysis. Eur J Pediatr 151:540–542
Sinai-Trieman L, Salusky IB, Fine RN (1989) Use of subcutaneous recombinant erythropoietin in children undergoing continuous cycling peritoneal dialysis. J Pediatr 114:550–554
References
Navarro M, Alonso A, Avilla JM, Espinosa L (1991) Anemia of chronic renal failure: treatment with erythropoietin. Child Nephrol Urol 11: 146–151
Scigalla P (1992) Effect of different routes of recombinant human erythropoietin (rhEPO) in children with end stage renal failure (ESRD). Proceedings of the ninth Congress of the International Pediatric Nephrology Association: 141A
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lane, W., Robson, M., Leung, A.K.C. et al. The cost associated with intraperitoneal versus subcutaneous administration of erythropoietin. Eur J Pediatr 152, 377 (1993). https://doi.org/10.1007/BF01956759
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01956759